Female genital tract shedding of CXCR4-tropic HIV type 1 is associated with a majority population of CXCR4-tropic HIV type 1 in blood and declining CD4+ cell counts

AIDS Research and Human Retroviruses

Volumn 28, Issue 11, 2012, Pages 1524-1532

  Haaland, Richard E ^a   Sullivan, Sharon T ^a   Evans Strickfaden, Tammy ^a   Lennox, Jeffrey L ^b   Hart, Clyde E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHLAMYDIA TRACHOMATIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE GENITAL SYSTEM; GENOTYPE; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PREDICTIVE VALUE; PRIORITY JOURNAL; SPECIES; TRICHOMONAS VAGINALIS; UNINDEXED SEQUENCE; VAGINAL SECRETION; VIRAL TROPISM; VIRUS ENVELOPE; VIRUS LOAD; VIRUS SHEDDING;

ADULT; CD4 LYMPHOCYTE COUNT; CELL LINE; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; RECEPTORS, CXCR4; VAGINA; VIRAL TROPISM; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 84868542868     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0004     Document Type: Article

References (54)

1. Bonhoeffer S, Holmes EC, and Nowak MA: Causes of HIV diversity. Nature 1995;376:125.
2. Gao F, Chen Y, Levy DN, et al.: Unselected mutations in human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol 2004;78:2426-2433.
3. Malim MH and Emerman M: HIV-1 sequence variation: Drift, shift, and attenuation. Cell 2001;104:469-472.
4. Saag MS, Hahn BH, Gibbons J, et al.: Extensive variation of human immunodeficiency virus type 1 in vivo. Nature 1988;334:440-444.
5. Albert J, Abrahamsson B, Nagy K, et al.: Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990;4:107-112.
6. Altfeld M, Rosenberg ES, Shankarappa R, et al.: Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169-180.
7. Arendrup M, Nielsen C, Hansen J-ES, et al.: Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J Acquir Immune Defic Syndr 1992;5:303-307.
8. Coffin JM: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;267:483-489.
9. Doukhan L and Delwart E: Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay. J Virol 2001;75:6729-6736.
10. Hance AJ, Lemiale V, Izopet J, et al.: Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J Virol 2001;75:6410-6417.
11. Kijak GH, Simon V, Balfe P, et al.: Origin of human immunodeficiency virus type 1 quasispecies emerging after anti-retroviral treatment interruption in patients with therapeutic failure. J Virol 2002;76:7000-7009.
12. Pastore C, Ramos A., and Mosier DE: Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching. J Virol 2004;78:7565-7574.
13. De Pasquale PM, Brown AJL, Uvin SC, et al.: Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy. J Acquir Immune Defic Syndr 2003;34:37-44.
14. Kemal KS, Foley B, Burger H, et al.: HIV-1 in genital tract and plasma of women: Compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Natl Acad Sci USA 2003;100:12972-12977.
15. Poss M, Rodrigo AG, Gosink JJ, et al.: Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol 1998;72:8240-8251.
16. Zhu T, Wang N, Carr A, et al.: Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996;70:3098-3107.
17. Artenstein AW, VanCott TC, Sitz KV, et al.: Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information. J Infect Dis 1997;175:265-271.
18. Belec L, Dupre T, Prazuck T, et al.: Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:691-697.
19. Ellerbrock TV, Lennox JL, Clancy, KA, et al.: Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis 2001;184:28-36.
20. Tirado G, Jove G, Kumar R, et al.: Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations. Virology 2004;324:577-586.
21. van't Wout AB, Kootstra NA, Mulder-Kampinga GA, et al.: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994;94:2060-2067.
22. Milich L, Margolin BH, and Swanstrom R: Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 env protein. Virology 1997;239:108-118.
23. Wolfs TFW, Zwart G, Bakker M, and Goudsmit J: HIV-1 genomic RNA diversification following sexual and paren-teral virus transmission. Virology 1992;189:103-110.
24. Zhu T, Mo H, Wang N, et al.: Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-1181.
25. Hladik F, Lentz G, Delpit E, et al.: Coexpression of CCR5 and IL-2 in human genital but not blood T cells: Implications for the ontogeny of the CCR5 Th1 phenotype. J Immunol 1999;163:2306-2313.
26. Greenhead P, Hayes P, Watts PS, et al.: Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000;74:5577-5586.
27. Mostad SB and Kreiss JK: Shedding of HIV in the genital tract. AIDS 1996;10:1305-1315.
28. Royce RA, Sena A, Cates W, and Cohen MS: Sexual transmission of HIV. N Engl J Med 1997;336:1072-1078.
29. Koot M, Keet IP, Vos AH, et al.: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-688.
30. Shankarappa R, Margolick JB, Gange SJ, et al.: Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999;73:10489-10502.
31. Hart CE, Lennox JL, Pratt-Palmore M, et al.: Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999;179:871-882.
32. Davies A: A preliminary investigation using p-nitrophenyl phosphate to quantitate acid phosphatase on swabs examined in cases of sexual assault. Med Sci Law 1978;18:174-178.
33. Mulder J, McKinney N, Christopherson C, et al.: A rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
34. Chen J, Young NL, Subbarao S, et al.: HIV type 1 subtypes in Guangxi Province, China, 1996. AIDS Res Hum Retroviruses 1999;15:81-84.
35. Brumme ZL, Dong WW, Yip B, et al.: Clinical and immu-nological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy. AIDS 2004;18:F1-F9.
36. Jensen MA, Li FS, van 't Wout AB, et al.: Improved cor-eceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 2003;77:13376-13388.
37. Myers G and Lenroot R: HIV glycosylation: What does it portend? AIDS Res Hum Retroviruses 1992;8:1459-1460.
38. Marshall RD: The nature and metabolism of the carbohy-drate-peptide linkage of glycoproteins. Biochem Soc Symp 1974;40:17-26.
39. Nakayama EE, Shioda T, Tatsumi M, et al.: Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4 but not CCR-5-dependent fusion. FEBS Lett 1998;426:367-372.
40. Hart CE, Lennox JL, Pratt-Palmore M, et al.: Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999;179:871-882.
41. Sullivan ST, Mandava U, Evans-Strickfaden T, et al.: Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: Associations with immune status. J Virol 2005;79:9799-9809.
42. Wright TC Jr, Subbarao S, Ellerbrock TV, et al.: Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol 2001;184:279-285.
43. Connor RI, Sheridan KE, Ceradini D, et al.: Change in cor-eceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997:185:621-628.
44. Kelly KA and Rank RG: Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 1997;65:5198-208.
45. Olive AJ, Gondek DC, and Starnbach MN: CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mu-cosa. Mucosal Immunol 2011;4:208-216.
46. Salemi M, Burkhardt BR, Gray RR, et al.: Phylodynamics of HIV-1 in lymphoid and non-lymphoid tissues reveals a central role for the thymus in emergence of CXCR4-using quasispecies. PLoS One 2007;2:e950.
47. Back NKT, Smit L, De Jong J-J, et al.: An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 1994;199:431-438.
48. Schonning K, Jansson B, Olofsson S, et al.: Resistance to V3-directed neutralization caused by an N-linked oligosac-charide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology 1996;218:134-140.
49. Bunnik EM, Pisas L, van Nuenen AC, and Schuitemaker H: Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol 2008;82:7932-7941.
50. Bull ME, Learn GH, McElhone S, et al.: Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus. J Virol 2009;83:6020-6028.
51. Gantt S, Carlsson J, Heath L, et al.: Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J Virol 2010;84:10812-10819.
52. Salazar-Gonzalez JF, Salazar MG, Learn GH, et al.: Origin and evolution of HIV-1 in breast milk determined by singlegenome amplification and sequencing. J Virol 2011;85:2751-2763.
53. Bull M, Learn G, Genowati I, et al.: Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations. PLoS One 2009;4:e7122.
54. Kelley CF, Sullivan ST, Lennox JL, et al.: Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence in antiretroviral-experienced women. AIDS 2010; 24:1361-1366.